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Human pluripotent stem cells (PSC) acquire recurrent chromosomal instabili-
ties during prolonged in vitro culture that threaten to preclude their use in cell-
based regenerative medicine. The rapid proliferation of pluripotent cells leads
to constitutive replication stress, hindering the progression of DNA replication
forks and in some cases leading to replication-fork collapse. Failure to over-
come replication stress can result in incomplete genome duplication, which, if
left to persist into the subsequent mitosis, can result in structural and numerical
chromosomal instability.
We have recently applied the DNA iber assay to the study of replication stress
in human PSC and found that, in comparison to somatic cells states, these cells
display features of DNA replication stress that include slower replication fork
speeds, evidence of stalled forks, and replication initiation from dormant repli-
cation origins. These indings have expanded on previous work demonstrating
that extensive DNA damage in human PSC is replication associated. In this
capacity, the DNA iber assay has enabled the development of an advanced
nucleoside-enriched culture medium that increases replication fork progression
and decreases DNA damage and mitotic errors in human PSC cultures.
The DNAiber assay allows for the study of replication fork dynamics at single-
molecule resolution. The assay relies on cells incorporating nucleotide analogs
into nascent DNA during replication, which are then measured to monitor sev-
eral replication parameters. Here we provide an optimized protocol for the iber
assay intended for use with human PSC, and describe the methods employed
to analyze replication fork parameters. © 2020 Wiley Periodicals LLC.
Basic Protocol 1: DNA iber labeling
Basic Protocol 2: DNA iber spreading
Basic Protocol 3: Immunostaining
Support Protocol 1:Microscopy/data acquisition
Support Protocol 2: Data analysis
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INTRODUCTION
Human pluripotent stem cells (PSC) possess the ability to endlessly renew and differ-
entiate into any cell type of the body, making them a promising resource for cell-based
regenerativemedicine (Takahashi et al., 2007, Thomson et al., 1998). To capitalize on this
potential, researchers may need to expand PSC for long periods of time in a genetically
stable and undifferentiated state. However, recurrent genetic changes have been reported
to arise during prolonged in vitro culture (Draper et al., 2004, Olariu et al., 2010). These
changes occur throughmutation and subsequent selection of variant cells in which the ge-
netic change provide a growth advantage (Avery et al., 2013, Blum, Bar-Nur, Golan-Lev,
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Figure 1 A schematic of the DNA fiber assay. (A) Labeling of nascent DNA with CldU and IdU
nucleotide analogs. (B) Preparation of the cell lysate solution for DNA spreading. (C) DNA spread-
ing. The microscope slide is tilted at an angle of 25°-40°C, and the cell lysate droplet is allowed to
run the length of the slide. It should take between 3 and 5 min for the droplet to spread the length
of the microscope slide. (D) The spread DNA is dried and fixed. (E) The DNA fibers are immuno-
labeled and confocal images are acquired for analysis. This figure has been reproduced in part,
with permission, from Quinet et al. (2017).
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& Benvenisty, 2009). Although extensive resources have been applied to understanding
the mechanism of selection, comparatively little is known about the mechanism of mu-
tation in these cells.
DNA damage and genome stress, including replication stress, can lead to genetic in-
stability like that often observed in cancer (Burrell et al., 2013). Previous studies have
highlighted that human PSC are prone to replication stress and DNA damage (Halliwell
et al., 2020, Simara et al., 2017, Vallabhaneni et al., 2018), which may also drive the
high frequency of mitotic errors that has been reported elsewhere (Lamm et al., 2016,
Zhang et al., 2019). Yet, despite this, the underlying mutation rate in these cells is low
(Thompson et al., 2020). This apparent contradiction can be reconciled by observations
that cell cycle checkpoints such as CHK1, responsible for relay signaling in response to
replication stress, are relaxed in human PSC, causing these cells to die in response to
genomic damage (Desmarais et al., 2012, Desmarais, Unger, Damjanov, Meuth, & An-
drews, 2016). These characteristics may relect the requirements of early embryogenesis,
where a relentless need to proliferate while maintaining genetic stability is critical to en-
sure successful development. Nevertheless, this system is not perfect and mutations still
arise both in vivo and in vitro.
To better understand the origins of genome instability in human PSC, the appropriate
assays must be optimized for use in these systems. The DNA iber assay has become the
gold standard in directly monitoring DNA replication fork dynamics, and is thus an im-
portant tool for the understanding of DNA replication stress. However, its application has
been primarily focused on understanding replication in cancer cell lines (Nieminuszczy,
Schwab, & Niedzwiedz, 2016). This article describes the basic protocols required to per-
form the DNA iber assay in human PSC: the sequential pulse labeling of actively repli-
cating DNA (Basic Protocol 1), spreading of labeled DNA ibers onto glass slides (Basic
Protocol 2), immunolabeling of nascent DNA ibers (Basic Protocol 3) for visualization
by confocal microscopy (Support Protocol 1), and data analysis and replication event
characterization (Support Protocol 3) will be described (Fig. 1). Using our protocol, DNA
iber length, replication fork speed, inter-replication origin distance, and fork symme-
try can be measured, and replication events including the detection of stalled/terminated
forks, new origins, bidirectional forks, and fork terminations can be quantiied.
The protocols in this article have been successfully used to monitor replication dynamics
in several human iPSC and ES cell lines cultured in feeder-free conditions using mTeSR,
Nutristem, or E8 on a matrix of recombinant vitronectin−coated plates (Halliwell et al.,
2020).
BASIC
PROTOCOL 1
DNA FIBER LABELING
This protocol describes the pulse labeling of DNA and harvesting of the labeled human
PSC intended for use in the DNA iber assay. Human PSC should be seeded at least 48 hr
before starting the experiment. Pulse labeling is performed sequentially with two thymi-
dine analogs—chlorodeoxyuridine (CldU) and iododeoxyuridine (IdU)—for 20min each
(Fig. 1A). DNA labeling exploits the ability of in vitro−cultured cells to incorporate nu-
cleotide analogs into newly replicating DNA strands. To ensure consistent and robust
labeling, the cells should be at ∼50% conluency at the start of the experiment: this will
ensure the cells are still in the growth phase and replication is not suppressed. Further, the
labeling time should be strictly monitored. A deviation in timing will introduce inaccu-
racy and confound experimental results. Once labeled, the cells should be dissociated into
single cells using TrypLE, to minimize stress and allow for accurate cell counting. Dis-
sociated cells should be kept on ice to inhibit further enzymatic activity before spreading
(Basic Protocol 2).
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This protocol should produce a homogenous single-cell suspension of pulse-labeled cells
in ice-cold PBS for DNA spreading (Basic Protocol 2).
Materials
1× PBS (see recipe)
Human PSC culture medium: mTeSR 1 (STEMCELL Technologies, 85850), E8 (in
house; Chen et al., 2011), or Nutristem XF (Biological Industries, 05-100-1A)
Rho-associated, coiled-coil containing protein kinase 1 inhibitor (Y-27632; see
recipe)
One T-12.5 lask of human embryonic or induced pluripotent stem cells
TrypLE Express single-cell dissociation solution (Life Technologies, 12604-021)
2.5 mM 5-chloro-2′-deoxyuridine (CldU) stock solution (see recipe)
2.5 mM 5-iodo-2′-deoxyuridine (IdU stock solution (see recipe)
Ice cold 1× Dulbecco’s phosphate buffered saline (PBS; see recipe)
Vitronectin-coated 6-well plate (see recipe)
15-ml conical centrifuge tubes (Falcon or equivalent)
Cell counter
Centrifuge
Seed human PSC for DNA labeling
1. Add 2 ml of human PSC culture medium, supplemented with Y-27632 (1:1000), to
each well of a vitronectin-coated 6-well plate. Pre-warm the plate for 30 min at 37°C
in a 5% CO2 incubator to allow the vitronectin to set.
2. Aspirate the cell culture medium from the T-12.5 lask of human PSC.
3. Add 1 ml TrypLE to the T-12.5 lask and incubate for 3 min at 37°C in a 5% CO2
incubator.
4. Add 4 ml of human PSC culture medium to the T-12.5 lask to detach the cells.
Transfer the cell suspension into a 15-ml tube.
5. Count the total cell number and centrifuge the cells 3 min at 300× g, room temper-
ature, then resuspend the pellet in 1 ml human PSC culture medium.
6. Seed 80,000 cells per well of the 6-well plate prepared in step 1. Culture for 72 hr
(minimum of 48 hr, although cell numbers will need to be adjusted accordingly)
with daily batch feeding, removing the Y-27632 after 24 hr.
DNA pulse labeling
7. Prewarm CldU and IdU stock solutions to 37°C.
8. Prewarm TrypLE solution to 37°C.
9. Add CldU stock solution to the seeded cells (from step 1-6) for a inal concentration
of 25 µM (Fig. 1A).
10. Incubate for precisely 20 min at 37°C in a 5% CO2 incubator.
11. Add IdU stock solution to the seeded cells for a inal concentration of 250 µM
(Fig. 1A).
The concentration of IdU is 10-fold higher than the concentration of CldU. This is to
ensure that IdU displaces CldU during the second pulse-labeling step. The addition of
the second analog must be performed promptly following the 20-min incubation with the
irst analog.
12. Incubate for precisely 20 min at 37°C in a 5% CO2 incubator.
Halliwell et al.
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13. Aspirate the medium.
14. Wash twice, each time with 2 ml ice-cold PBS, aspirating medium after each wash.
Steps 13 to 14 should be performed rapidly to avoid over-labeling of nascent DNA.
15. Add 1 ml pre-warmed TrypLE solution to each well. Coat the wells thoroughly and
aspirate off the excess solution.
16. Incubate for 3 min.
17. Aspirate off the excess TrypLE and add 0.5 ml ice-cold PBS to release the cells from
the 6-well plate. Transfer the cell suspension to a 15-ml conical tube.
18. Count the total cell number and dilute with ice-cold PBS to 400,000 cells per ml.
19. Keep on ice and spread (Basic Protocol 2) within 30 min.
BASIC
PROTOCOL 2
DNA SPREADING
This protocol aims to describe the technique of DNA spreading (Parra & Windle, 1993).
Following DNA labeling (Basic Protocol 1), a small droplet of cell suspension is lysed
on a glass slide (Fig. 1B) and then tilted to allow spreading. The droplet of cell lysate
solution generates cohesive tension with the slide as it runs its length, stretching the DNA
into ibers that can be later stained and visualized by immunoluorescence (Basic Protocol
3 and Support Protocol 1).
The major factor requiring optimization in this protocol is the type of glass slide used.
Before initiating this protocol, different brands and batches of slides should be tested to
ensure the droplet runs slowly down the length of the glass slide when tilted at 25°-40°. If
this protocol is conducted properly, a droplet of cell lysate solution should run the length
of a glass slide in 3 to 5 min. Once dried, the path of the droplet should leave behind a
cloudy precipitate. Depending on the temperature and humidity, it may be necessary to
alter the volume of the spreading buffer or the angle at which the slide is tilted to ensure
that the droplet runs at a slow, constant rate.
Materials
Cell suspension (Basic Protocol 1)
Spreading buffer (see recipe)
Methanol/acetic acid ixative (see recipe)
Super premium microscope slides (BDH Laboratory Supplies)
Other slides are also suitable, although each batch should be tested to optimize
spreading.
The lid of a multi-well plate (or something similar) to hold the tilted slides in place
Cell lysis
1. Working with one sample at a time, pipette 2 µl of ice-cold cell suspension at the
top of each of 3-5 microscope slides, depending on the number of replicates to be
performed (Fig. 1B).
Be sure that the droplet does not touch the frosted end of the slide, as this will inhibit its
ability to spread. It is a good idea to mark with pencil the position of the cell suspension,
to aid in inding the ibers on the microscope.
2. Allow to dry for 5-7 min.
This step will require optimization. Look for the edges of the droplet beginning to dry
and for the droplet to become tacky. The time that this takes may vary depending on room
temperature and humidity. However, do not allow the droplet to completely dry.
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3. Add ∼7 µl of spreading buffer and stir with a pipette tip (Fig. 1B).
To ensure that the droplet spreads down the slide slowly (step 5 to 6), the volume of
spreading buffer may need to be adjusted.
IMPORTANT NOTE: Stir with the pipette tip; do NOT pipette up and down.
4. Incubate for 2 min.
Spreading
5. Tilt each slide at an angle of 25° to 40° and hold in place on the lid of a multi-well
plate.
6. Let the droplet run down the slide slowly and at a constant speed. The droplet should
reach the bottom edge after 3 to 5 min (Fig. 1C).
It is important to ensure that the droplet spreads slowly and at a constant speed, so that
the ibers do not clump and become uncountable during the analysis steps.
7. Lay the slides lat and allow to air dry completely (approximately 15 min).
8. Go back to step 1 and prepare the next sample.
Fixation
9. Using a 1-ml pipette, gently add 1 ml methanol/acetic acid ixative to the bottom
right-hand corner of the slide and allow it to spread over the entirety of the slide
(Fig. 1D).
10. Incubate for 10 min.
11. Tilt the slide to allow the excess ixative to run off, and allow to air dry completely.
At this point, the slides can be stored at 4°C overnight.
BASIC
PROTOCOL 3
IMMUNOSTAINING
This protocol describes the immunolabeling of DNA ibers spread onto glass slides. The
protocol begins with an acid treatment to denature the DNA ibers before blocking for
unspeciic binding and labeling the CldU and IdU labeled ibers with rat and mouse anti-
BrdU primary antibodies, respectively. Detection of the labeled DNA ibers is possible
by immunostaining with luorescently labeled secondary antibodies (Fig. 1E).
Following this immunostaining protocol, it will be possible to detect the labeled DNA
ibers by confocal microscopy. The labeled DNA should be detectable as bi-labeled ibers
in the 555 and 488Alexa Fluor visible spectrum. Further details and expected results from
this protocol can be found in the “Understanding Results” section.
Materials
Slides with spread DNA ibers (Basic Protocol 2)
2.5 M hydrochloric acid (see recipe)
1× PBS (see recipe)
Blocking solution (see recipe), pre-chilled
Rat monoclonal anti-BrdU antibody [BU1/75 (ICR1)] (Abcam, ab6326)
Mouse monoclonal anti-BrdU antibody (clone B44) (Becton Dickson, 347580
(7580))
4% paraformaldehyde (PFA; see recipe)
Alexa Fluor 555 goat anti−rat IgG (Thermo Fisher Scientiic, A21434)
Alexa Fluor 488 F (ab′)2 goat anti−mouse IgG (Thermo Fisher Scientiic,
A-11017)
Fluoroshield mounting medium (Sigma, F6182)Halliwell et al.
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Glass staining troughs with slide racks (e.g., Sigma, BR472200)
Coplin staining jar (e.g., Sigma, S5766)
Coverslips, 60 × 22 mm (ThermoFisher Scientiic, BB02200600A113MNT0)
Wash, denature, and block
1. Wash slides twice with double-distilled H2O in a staining trough.
All wash steps should be performed by placing slides in a slide rack, submerging in the
wash solution within a staining trough, and agitating back and forth twice.
2. Rinse the slides once in 2.5 M hydrochloric acid in a staining trough.
All rinse steps should be performed by dipping the slides, held in a slide rack, in and out
of the rinse solution within a staining trough.
3. Denature in 2.5 M hydrochloric acid in a staining trough for 1 hr.
4. Rinse the slides twice with 1× PBS.
5. Wash the slides twice with blocking solution in a Coplin jar.
To wash, place slide inside Coplin jar then add blocking solution; after irst wash, pour
out the buffer and replace with fresh buffer.
6. Incubate the slides in fresh blocking solution in the Coplin jar for 1 hr.
Primary antibody immunolabeling
7. Make a fresh solution of primary antibodies by mixing rat monoclonal anti-BrdU
antibody (1:500) and mouse monoclonal anti-BrdU antibody (1:500) in blocking
solution.
Antibodies should be titered, as the optimal concentration will depend on the source and
nature of the antibody.
8. Using a 1-ml pipette, gently add 750 µl of the antibody solution to the bottom right-
hand corner of the slide and allow it to spread over the entirety of the slide.
To stop the solution from evaporating, this step should be performed on a damp paper
towel covered with a plastic lid. Alternatively, a slide staining tray can be used (e.g.,
Sigma, Z670146).
9. Incubate for 1 hr.
10. Rinse three times with 1× PBS in a staining trough. Remove the slides and stand
them upright on a paper towel to remove any excess PBS.
11. Using a 1-ml pipette, gently add 1 ml of 4% PFA to the bottom right-hand corner of
the slide and allow it to spread over the entirety of the slide.
12. Incubate for 10 min.
13. Rinse three times with 1× PBS in a staining trough.
14. Wash three times with blocking solution in a Coplin jar.
Secondary antibody immunolabeling
All steps should be performed in the dark to reduce photobleaching of the luorophore
labels. Use a dark staining trough and Coplin jar or wrap in aluminum foil to block the
light.
15. Make a fresh solution of secondary antibodies by mixing Alexa Fluor 555 goat anti-
rat IgG (1:500) and Alexa Fluor 488 F (ab′)2 goat anti−mouse IgG (1:500) in block-
ing solution.
Halliwell et al.
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Antibodies should be titered, as the optimal concentration will depend on the source and
nature of the antibody.
16. Using a 1-ml pipette, gently add 750 µl of the secondary antibody mix to the bottom
right-hand corner of the slide, and allow it to spread over the entirety of the slide
(Fig. 1E).
As before, this step should be performed on a damp paper towel covered with a plastic
lid. Alternatively, a slide staining tray can be used (e.g., Sigma, Z670146).
17. Incubate for 2 hr in the dark at room temperature
18. Rinse twice with 1× PBS in a staining trough.
19. Wash three times with blocking solution in a Coplin jar.
20. Rinse twice with 1× PBS in a staining trough.
21. Using Fluoroshield, mount a coverslip onto the glass slide and allow to dry for
30 min in the dark.
To avoid bubbles while mounting the coverslip, place one end of the coverslip lush with
the slide and slowly lower the other end. Store the slides at −20°C for up to 6 months.
SUPPORT
PROTOCOL 1
MICROSCOPY/DATA ACQUSITION
In support of the basic protocols above, we provide microscopy parameters and data-
acquisition instructions to facilitate accurate data analysis (Support Protocol 2). It is im-
portant to take pictures of ibers from across the entire slide where ibers do not overlap,
in order to ensure that robust measurements will be obtained. In total, 150-200 ibers
should be acquired per experimental condition to enable reliable estimation of replica-
tion parameters. Three or more independent repeats should be performed.
Microscopy parameters
The parameters in Table 1 have provided robust measurements when using an Olympus
FV1000 confocal microscope.
SUPPORT
PROTOCOL 2
DATA ANALYSIS
This protocol will describe the data analysis and replication-event characterization that
can be achieved from DNA iber assays as described above. In particular, we will de-
scribe how tomeasureDNAiber length, replication fork speed, fork symmetry, and inter-
replication origin distance, and how to detect and quantify different replication events.
Table 1 Microscopy Parameters
Parameter Setting Description/notes
Objective ×63 Oil-immersion lens
Channel (CldU) 568 Detection of CldU-labeled Alexa Fluor 555 label
Channel (IdU) 488 Detection of IdU-labeled Alexa Fluor 488 label
Zoom 1 Increasing the zoom will limit the number of ibers
per ield and could confound measurements (Support
Protocol 2)
Scan format 1080 × 1080 Number of pixels in the ield
Scan speed ∼8 µs This can be optimized to produce the best image
quality while minimizing photobleaching
File export TIFF Contains metadata of scaleHalliwell et al.
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Lorem ipsum
Figure 2 Representative image showing a single field of DNA fibers. The image was taken using
the described microscopy parameters (see Support Protocol 1 and Table 1). The fibers within the
field show minimal overlap and can be easily measured. Analysis of fields with a high density of
DNA fibers can confoundmeasurements, as they are likely to overlap, hindering their measurement
from end-to-end. The DNA fibers pictured were labeled sequentially with CldU and IdU for 20 min
each. Scale bar = 50 µm.
In each case, a total of 150-200 ibers should be analyzed per condition for a reliable esti-
mation of iber length, and to account for the range of iber lengths that can be attributed
to the varied dynamics of replication forks. Only clear ibers that do not overlap should
be included (Fig. 2). It is also important to image ibers from across the entire slide to
ensure robust measurement of replication fork dynamics. Data should be plotted as scat-
ter dot plots, or in box-and-whiskers plots. Statistical signiicance between two groups is
normally assessed using the Mann-Whitney U test (unpaired and nonparametric).
Materials
TIFF images from Support Protocol 1
ImageJ software (Schneider, Rasband, & Eliceiri, 2012)
Determining DNA iber length (µm)
The following steps are for determining total length covered by the replication fork within
the 40-min pulse labelings.
1. Open each TIFF image from Support Protocol 1 in ImageJ.
2. In the Analyze menu, select measure.
Halliwell et al.
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3. For each iber, measure the length of the CldU (red) followed by the IdU (green).
4. Find the sum of the red and green lengths (Fig. 3A).
Determining replication fork speed of a progressing fork
The following steps are for determining the average speed of the replication fork over the
two sequential 20-min pulse labelings.
5. Perform steps 1-3.
6. Find the average length of each of CldU and IdU.
7. Divide by the pulse length (20 min).
8. To convert from µm/min to kb/min, a commonly used conversion factor of 2.59 kb
per µm (Jackson & Pombo, 1998; Fig. 3A) can be applied.
Fork symmetry
The following steps are for analysis of the synchronized progression of sister forks ema-
nating from a single origin. Fork asymmetry suggests replication-fork stalling events.
This analysis is performed on ibers that have contiguous IdU-CldU-IdU (green-red-
green) signals.
9. Perform steps 1-2.
10. Measure the length of the two IdU (green) tracts emanating from a single CldU (red)
origin (Fig. 3B).
11. Calculate the ratio between the two green tracts.
Inter-origin distance
The following steps are for determining distance between origins in two consecutive
DNA tracts. Care should be taken when measuring the inter-origin distance using the
DNA spreading technique, selecting only consecutive DNA tracts that are certain to be
on the same DNA iber. Ideally, DNA should be counterstained with a luorescent dye,
such as YOYO-1.
12. Perform step 1-2.
13. Measure the distance between two CldU (red) tracts of two consecutive and con-
tiguous IdU-CldU-IdU (green-red-green) ibers (Fig. 3C).
Replication events
The frequency of replication events, detailed in Figure 3, can be quantiied and normal-
ized to the total number of ibers present. These measurements can provide insight into
replication response to loss of protein or replication stress.
REAGENTS AND SOLUTIONS
Blocking solution
Thoroughly dissolve 5 g BSA and 0.5 ml of Tween 20 in 500 ml of 1× Dulbecco’s
PBS (see recipe). Make fresh and chill to 4°C prior to use.
CldU stock solution, 25 mM
Dissolve 6.6 mg CldU (Sigma, C6891) in 10 ml DMEM/F12 medium (Sigma,
D6421). Vortex until fully dissolved. Divide into 0.25-ml aliquots and store at−20°C
for up to 1 year.
Halliwell et al.
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Figure 3 Replication dynamics analysis and replication event characterization. Representative
images of DNA replication events with the directionality of the CldU and IdU labeling presented.
A description of the replication event is shown, and where relevant the formula required in the
calculation of the specified replication dynamic is shown. (A) Ongoing replication fork. Analysis
of these forks can be used to determine the fiber length and replication fork speed using the for-
mulae shown. (B) Example of a bi-directional replication fork. Analysis of these fibers allows for
the quantification of fork symmetry; loss of symmetry indicates that replication fork stalling has
occurred. (C) Double replication origins allow for the distance between replication initiation sites
to be measured. Inter-origin distance is a measure of the density of origin firing, which is often a
symptom of replication stress in response to oncogene activation. (D) A representative image of
replication fork termination. Two forks travelling in opposite directions, which meet and terminate
fork progression. (E) The image shows the firing of a replication fork from a new origin of repli-
cation, which has occurred during the second pulse labeling with IdU. The presence of IdU-only
(See next page for legend) Halliwell et al.
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tracts is a sign of origin firing, as the fork was not progressing during the period of the first labeling.
(F) CldU-only labeled fibers indicate the stalling or collapse of replication forks prior to the ad-
dition of the second, IdU label. Quantification of CldU-only fibers, relative to the total number of
fibers, can be used to indicate replication stress, and may be a prerequisite to genome instability.
(G) Hydroxyurea arrests DNA replication in human PSC. The image shows the severely slowed or
stalled progression of replication forks of hydroxyurea-treated human PSC. Scale bars = 10 µm.
Dulbecco’s PBS, 1×
Dilute 10× concentrate stock, without calcium andmagnesium (Sigma, D1408) 1:10
with double-distilled H2O. Autoclave the 1× solution before use. Store up to 1 year
at room temperature.
Hydrochloric acid, 2.5 M
Slowly add 83.2 ml hydrochloric acid (Sigma, 320331) to 316.8 ml double-distilled
H2O. Prepare fresh for each use.
IdU stock solution, 25 mM
Dissolve 6.6 mg IdU (Sigma, I7125) in 10 ml DMEM/F12 medium (Sigma, D6421).
Heat to 60°C and vortex for 5 min to dissolve. Make 0.25-ml aliquots and store at
−20°C for up to 1 year.
Methanol/acetic acid ixative
Mix methanol (Sigma, 179337) and acetic acid (Sigma, 695092) at a 3:1 ratio. For
example, to make 50 ml of ixative, mix 37.5 ml of methanol with 12.5 ml acetic
acid. Store at room temperature in an air-tight container for up to 1 year.
Paraformaldehyde solution, 4%
Dilute 8% paraformaldehyde solution (see recipe) in 1×Dulbecco’s PBS (see recipe)
at a 1:1 ratio. Store up to 2 weeks at 4°C.
Paraformaldehyde solution, 8%
Add 40 g of paraformaldehyde (Sigma, P6148) to 400 ml double-distilled H2O. Heat
the solution to 60°C and stir at a medium speed under a fume hood. Add∼10 drops of
1 N NaOH to dissolve the PFA granules. Continue to mix for 2 hr. Allow the solution
to cool, and add double-distilled H2O for a total volume of 500 ml. Aliquot and store
at −20°C for up to 1 year.
Rho-associated, coiled-coil containing protein kinase 1 inhibitor (Y-27632)
Dissolve Y-27632 dihydrochloride (TOCRIS, 1254) in DMSO (Sigma, 472301) for
a 10 mM stock solution. Store for up to 1 year at −20°C.
Spreading buffer
Solution 1: Dissolve 3.152 g of Tris hydrochloride in 40 ml of double-distilled H2O
and adjust to pH 7.4.
Solution 2: Dissolve 1.46 g of disodium EDTA in 40 ml of double-distilled H2O.
Combine solution 1 and 2 and add 0.5 g SDS. Make the solution up to 100 ml with
double-distilled H2O and vortex to dissolve. Store at room temperature for up to 1
year.
Vitronectin-coated 6-well plate
Thaw 120 µl vitronectin recombinant protein (ThermoFisher Scientiic, A14700) at
room temperature and combine with 11.88 ml of 1× Dulbecco’s PBS (see recipe).
Mix well and add 2 ml to each well of a 6-well cell culture plate. Incubate at room
temperature for 1 hr. For longer-term storage, keep at 4°C and use within 2 weeks.
Halliwell et al.
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COMMENTARY
Background Information
Human PSC hold great promise in the ield
of regenerativemedicine. Yet, in order to reach
the full potential of these cells, we must irst
capitalize on their ability to rapidly and end-
lessly renew to generate large numbers of
genetically stable and undifferentiated cells.
However, it has become apparent that human
PSC acquire genetic changes during long-term
culture, which raise concerns over the safety
of stem cell−derived products that are des-
tined for the clinic (Draper et al., 2004, Olariu
et al., 2010). The recurrent nature of certain
karyotypic changes, such as ampliications to
chromosomes 1q, 12p, 17q, and 20q, have
highlighted that certain mutations provide a
growth advantage to the variant cell, which
becomes selected for in a culture over time
(Amps et al., 2011, Baker et al., 2016, Olariu
et al., 2010). Despite the mechanism of selec-
tion now being well deined, relatively little is
known about the underlying mutational mech-
anisms, although the observations of replica-
tion stress and genomic damage in human PSC
are similar to the oncogene-induced model
of genetic instability in cancer development
and progression (Halazonetis, Gorgoulis, &
Bartek, 2008). The self-renewal of human PSC
is characterized by an abbreviated G1 phase
that bypasses the Rb/E2F checkpoint and is
driven by high expression of cyclin D2 and
constitutive expression of cyclin E (Becker
et al., 2006, Filipczyk, Laslett, Mummery, &
Pera, 2007). Maintaining this rapid prolifera-
tion over extensive culture periodsmay expose
these cells to replication stress, characteristics
of which, such as reduced replication rates,
have been deined in human PSC using the
DNA iber assay (Halliwell et al., 2020). Fur-
thermore, we have recently identiied regions
of microhomology at the breakpoint of chro-
mosome 20 tandem ampliication, which im-
plicates that template-switching mechanisms
at stalled or collapsed forks are responsible for
thesemutations (J.A. Halliwell, D. Baker, P.W.
Andrews, I. Barbaric, unpub. observ.). Collec-
tively, these studies have determined that ge-
netic stability in human PSC is overtly linked
to DNA replication. This article provides ex-
perimental details and protocols required to
perform the DNA iber assay, which have been
optimized for studying replication stress in hu-
man PSC.
The DNA iber assay has become the gold-
standard assay in direct monitoring of DNA
replication-fork dynamics. The protocols de-
scribed here are based on the previously de-
scribed DNA iber assay (Merrick, Jackson, &
Difley, 2004), which itself was modiied from
the original DNA iber labeling (DIRVISH)
technique (Jackson & Pombo, 1998). Two dis-
tinguishable modiied nucleotides, CldU and
IdU, are added sequentially to the cell cul-
ture medium to pulse label nascent DNA
strands. The labeled nascent DNA is then re-
moved from the cells by lysis and stretched
onto glass slides. By tilting the glass slide,
the droplet of DNA solution runs down its
length under the force of gravity, stretching
the ibers as it runs (Parra & Windle, 1993).
Stretching the DNA by spreading is fast, and
requires little material or preparation. It is
therefore affordable and accessible to most re-
search laboratories. However, the DNA iber
assay described here has relatively low res-
olution and does not detect ssDNA disconti-
nuities, which means that analysis of the re-
sults must be done carefully to ensure that
broken ibers and crossed ibers are not in-
cluded. The addition of replication-stalling
and DNA-damaging agents prior to and dur-
ing the DNA-labeling procedure can facili-
tate the study of fork progression following
stalling, and when encountering DNA lesions.
Human PSC are particularly sensitive to geno-
toxic agents, radiation, or agents used to in-
duce replication block, even at doses that have
little effect on cancer or somatic cells (Des-
marais et al., 2012; Desmarais et al., 2016;
Hyka-Nouspikel et al., 2012; Luo et al., 2012;
Simara et al., 2017). However, these exper-
iments have been reviewed extensively else-
where (Quinet, Carvajal-Maldonado, Lema-
con, & Vindigni, 2017).
The procedure described in this article has
been optimized for use with human PSC, and
has been successfully applied to several hu-
man iPSC and human ESC cell lines (Hal-
liwell et al., 2020). We have utilized this
assay to improve culture conditions: sup-
plementing cultures with nucleosides allevi-
ates replication stress and decreases the fre-
quency of mitotic errors, highlighting that
these events are linked in human PSC (Hal-
liwell et al., 2020). The DNA iber assay
has revealed approaches that can be used to
reduce the appearance of genetic instability
in human PSC, which is necessary for the
safe application of human PSC in regenerative
medicine.
Halliwell et al.
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Table 2 Troubleshooting
Step Problem Possible reason Solution
Basic Protocol 1
(step 18)
Too many overlapping
DNA ibers
Density of labeled cells for
spreading is too high
Dilute the harvested labeled cell
solution
Basic Protocol 2
(step 6)
Fibers spreading occur
too slow or fast
Room temperature Increase or decrease the volume of
spreading buffer
Humidity Increase or decrease the slide tilt angle
Microscope slide Optimize spreading conditions for
each brand and batch of microscope
slides prior to use
Support Protocol 2 Inconsistent results
between biological and
technical replicates
Length of pulse labeling Ensure CldU or IdU is added for 20
min exactly
Time between cell
harvesting and spreading
Perform spreading sooner after cell
harvesting. Reduce the number of
samples to become more manageable.
Critical Parameters
We have observed little difference in iber
assay results whether human PSC are cul-
tured in mTeSR, E8, or Nutristem cell culture
medium. Currently, feeder layer−dependent
cell culture practices have not been tested. The
whole assay can be done in a single day, al-
though we have included a stop point follow-
ing the ixation step in Basic Protocol 2, which
allows the protocol to be run over a period of
2 days.
We advise allowing the human PSC to re-
cover for at least 48 hr following plating.
This will permit 24 hr in culture without
Rho-associated, coiled-coil containing protein
kinase 1 inhibitor (Y-27632). It will also allow
recovery from stressful re-plating, and for the
cells to re-enter logarithmic growth phase. It is
critical, where the results of experiments are to
be compared, that the density of cells initially
seeded and the conluency at the point of start-
ing the experiment be consistent. Higher con-
luency may cause cell proliferation and DNA
replication to slow.
With regard to labeling of DNA, it is pos-
sible to increase or decrease the pulse label-
ing times, but this will result in longer and
shorter DNA ibers, respectively. Again, the
labeling time must be constant across compa-
rable experiments. It is also important that the
labeling time be accurately measured. Devia-
tions one of 1 min will increase labeling by
5%, and will confound the results of the ex-
periment. To ensure timely labeling, it is ad-
vised that the reagents be prepared well ahead
of starting the experiment. Also, when adding
the second nucleotide analog (IdU), the plate
should be removed from the incubator 1 min
before the end of the irst incubation period, to
give a time buffer when preparing the second
label.
Once harvested, the cells should be sus-
pended in ice-cold PBS and kept on ice. DNA
spreading should then be performed within
30 min, to minimize cell death.
When spreading DNA ibers, the user
should select slides where the droplet spreads
down the length of the slide in 3 to 5 min at
a constant rate. In our experience, batches of
slides can differ from one another, and each
batch should be optimized.
Troubleshooting
Table 2 describes problems that can arise
with various steps in the assay, alongwith their
possible causes and Solutions.
Statistical Analysis
It is important to take images of ields
with minimum iber cross overs across the
whole slide to ensure a robust measurement
of the progressing replication forks. A min-
imum of 150-200 individual ibers must be
measured to account for the heterogeneity be-
tween progressing forks. The conversion fac-
tor for stretched DNA ibers is 2.59 kb/µm
(Jackson & Pombo, 1998).
Consideration should be given to the pre-
sentation of data. Histograms and scatter plots
are appropriate for capturing normal differ-
ences in replication fork progression. Statisti-
cal signiicance can be calculated using an un-
paired Mann-Whitney U-test.
Understanding Results
The DNA ibers produced can be variable
but, in our experience, under normal growth
Halliwell et al.
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conditions, they should contain equal lengths
of CldU and IdU staining. When measured,
we ind the replication fork speed to vary be-
tween 0.5 and 0.75 kb/min. A reduced iber
length or fork speed can indicate replication
stress.
Monitoring the frequency of replication
events can provide valuable information re-
garding the replication processes going on
during the culture of human PSC (Fig. 3).
A strict control of replication origin den-
sity is required to maintain chromosomal sta-
bility (Prioleau & MacAlpine, 2016). Ex-
cessive replication-origin iring can deplete
necessary protein and metabolites required
for eficient DNA replication (Sørensen &
Syljuåsen, 2012). A decrease in inter-origin
distance or a higher density of IdU-only la-
beled ibers is a measure of increased origin
density, suggesting greater numbers of simul-
taneously iring origins of replication. Fork
stalling is a prerequisite for DNA breakage,
which can become a substrate for genetic in-
stability (Toledo, Neelsen, & Lukas, 2017).
Measuring the frequency of CldU-only ibers
or the ratio of the IdU labels on a bi-directional
fork can be used to measure fork stalling. A
shorter IdU iber on one side of a bi-directional
fork implies a fork-stalling event, and will
result in a greater ratio between the IdU
tracts.
Time Considerations
Basic Protocol 1
Cells should be grown for a minimum of
48 hr following seeding; we have found 72 hr
to be optimal. Steps 1 to 6: ∼40 min will be
needed for cell seeding. ∼20 min per day will
be needed to refresh the medium.
Steps 7 to 18:∼1 hr will be needed to pulse
label and harvest the cells.
Basic Protocol 2
Step 1 to 4: preparation of cell lysate for
DNA spreading will require ∼15 min.
Step 5 to 7: DNA spreading will require
∼20 min for spreading one set of three slides
simultaneously.
Step 8 to 10: ixation of DNA ibers will
require ∼15 min.
Basic Protocol 3
Step 1 to 18: DNA immunolabeling steps
will require ∼6.5 hr.
Support Protocol 1 and 2
Several hours will be required for image
acquisition and data analysis, but this will be
variable depending on the quality of the DNA
ibers and the biological question being asked.
Acknowledgments
This project has received funding from the
European Union’s Horizon 2020 research and
innovation program under grant agreement
No. 668724.
This work was partly funded by the Eu-
ropean Union’s Horizon 2020 research and
innovation program under grant agreement
No. 668724 and partly by the UK Regen-
erative Medicine Platform, MRC reference
MR/R015724/1.
Literature Cited
Amps, K., Andrews, P. W., Anyfantis, G., Arm-
strong, L., Avery, S., Baharvand, H., … Zhou,
Q. (2011). Screening ethnically diverse human
embryonic stem cells identiies a chromosome
20 minimal amplicon conferring growth advan-
tage. Nature Biotechnology, 29, 1132–1144.
Avery, S., Hirst, A. J., Baker, D., Lim, C. Y., Ala-
garatnam, S., Skotheim, R. I., … Knowles, B.
B. (2013). BCL-XL mediates the strong selec-
tive advantage of a 20q11.21 ampliication com-
monly found in human embryonic stem cell cul-
tures. Stem Cell Reports, 1, 379–386. doi: 10.
1016/j.stemcr.2013.10.005.
Baker, D., Hirst, A. J., Gokhale, P. J., Juarez, M.
A., Williams, S., Wheeler, M., … Barbaric, I.
(2016). Detecting genetic mosaicism in cultures
of human pluripotent stem cells. Stem Cell Re-
ports, 7, 998–1012. doi: 10.1016/j.stemcr.2016.
10.003.
Becker, K. A., Ghule, P. N., Therrien, J. A., Lian, J.
B., Stein, J. L., VanWijnen, A. J., & Stein, G. S.
(2006). Self-renewal of human embryonic stem
cells is supported by a shortened G1 cell cy-
cle phase. Journal of Cellular Physiology, 209,
883–893. doi: 10.1002/jcp.20776.
Blum, B., Bar-Nur, O., Golan-Lev, T., & Ben-
venisty, N. (2009). The anti-apoptotic gene sur-
vivin contributes to teratoma formation by hu-
man embryonic stem cells. Nature Biotechnol-
ogy, 27, 281–287. doi: 10.1038/nbt.1527.
Burrell, R. A., Mcclelland, S. E., Endesfelder, D.,
Groth, P., Weller, M. C., Shaikh, N., … Swan-
ton, C. (2013). Replication stress links struc-
tural and numerical cancer chromosomal in-
stability. Nature, 494, 492–496. doi: 10.1038/
nature11935.
Chen, G., Gulbranson, D. R., Hou, Z., Bolin, J. M.,
Ruotti, V., Probasco, M. D., … Thomson, J. A.
(2011). Chemically deined conditions for hu-
man iPSC derivation and culture. Nature Meth-
ods, 8, 424–429. doi: 10.1038/nmeth.1593.
Desmarais, J. A., Hoffmann, M. J., Bingham, G.,
Gagou, M. E., Meuth, M., & Andrews, P. W.
(2012). Human embryonic stem cells fail to acti-
vate CHK1 and commit to apoptosis in response
to DNA replication stress. Stem Cells, 30, 1385–
1393. doi: 10.1002/stem.1117.
Halliwell et al.
15 of 16
Current Protocols in Stem Cell Biology
Desmarais, J. A., Unger, C., Damjanov, I., Meuth,
M., & Andrews, P. (2016). Apoptosis and fail-
ure of checkpoint kinase 1 activation in human
induced pluripotent stem cells under replication
stress. Stem Cell Research & Therapy, 7, 17.
Draper, J. S., Smith, K., Gokhale, P., Moore, H.
D., Maltby, E., Johnson, J., … Andrews, P. W.
(2004). Recurrent gain of chromosomes 17q and
12 in cultured human embryonic stem cells.
Nature Biotechnology, 22, 53–54. doi: 10.1038/
nbt922.
Filipczyk, A. A., Laslett, A. L., Mummery, C., &
Pera, M. F. (2007). Differentiation is coupled
to changes in the cell cycle regulatory appara-
tus of human embryonic stem cells. Stem Cell
Research, 1, 45–60. doi: 10.1016/j.scr.2007.09.
002.
Halazonetis, T. D., Gorgoulis, V. G., & Bartek,
J. (2008). An oncogene-induced DNA damage
model for cancer development. Science, 319,
1352–1355. doi: 10.1126/science.1140735.
Halliwell, J. A., Frith, T. J. R., Laing, O., Price,
C. J., Bower, O. J., Stavish, D., … Andrews,
P. W. (2020). Nucleosides rescue replication-
mediated genome instability of human pluripo-
tent stem cells. Stem Cell Reports, 14, P1009–
1017. doi: 10.1016/j.stemcr.2020.04.004.
Hyka-Nouspikel, N., Desmarais, J., Gokhale, P.
J., Jones, M., Meuth, M., Andrews, P. W., &
Nouspikel, T. (2012). Deicient DNA damage
response and cell cycle checkpoints lead to
accumulation of point mutations in human em-
bryonic stem cells. Stem Cells, 30, 1901–1910.
doi: 10.1002/stem.1177.
Jackson, D. A., & Pombo, A. (1998). Replicon clus-
ters are stable units of chromosome structure:
Evidence that nuclear organization contributes
to the eficient activation and propagation of S
phase in human cells. Journal of Cell Biology,
140, 1285–1295. doi: 10.1083/jcb.140.6.1285.
Lamm, N., Ben-David, U., Golan-Lev, T., Stor-
chová, Z., Benvenisty, N., & Kerem, B. (2016).
Genomic instability in human pluripotent stem
cells arises from replicative stress and chromo-
some condensation defects. Cell Stem Cell, 18,
253–261. doi: 10.1016/j.stem.2015.11.003.
Luo, L. Z., Gopalakrishna-Pillai, S., Nay, S. L.,
Park, S. W., Bates, S. E., Zeng, X., …O’connor,
T. R. (2012). DNA repair in human pluripotent
stem cells is distinct from that in non-pluripotent
human cells. PloS One, 7, e30541. doi: 10.1371/
journal.pone.0030541.
Merrick, C. J., Jackson, D., & Difley, J. F. (2004).
Visualization of altered replication dynamics af-
ter DNA damage in human cells. Journal of
Biological Chemistry, 279, 20067–20075. doi:
10.1074/jbc.M400022200.
Nieminuszczy, J., Schwab, R. A., & Niedzwiedz,
W. (2016). The DNA ibre technique—Tracking
helicases at work.Methods, 108, 92–98. doi: 10.
1016/j.ymeth.2016.04.019.
Olariu, V., Harrison, N. J., Coca, D., Gokhale,
P. J., Baker, D., Billings, S., … Andrews, P.
W. (2010). Modeling the evolution of culture-
adapted human embryonic stem cells. Stem Cell
Research, 4, 50–56. doi: 10.1016/j.scr.2009.09.
001.
Parra, I., & Windle, B. (1993). High resolution vi-
sual mapping of stretched DNA by luorescent
hybridization. Nature Genetics, 5, 17–21. doi:
10.1038/ng0993-17.
Prioleau, M. N., & Macalpine, D. M. (2016). DNA
replication origins—Where do we begin?Genes
& Development, 30, 1683–1697.
Quinet, A., Carvajal-Maldonado, D., Lemacon,
D., & Vindigni, A. (2017). DNA iber anal-
ysis: Mind the gap! Methods in Enzymol-
ogy, 591, 55–82. doi: 10.1016/bs.mie.2017.03.
019.
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W.
(2012). NIH Image to ImageJ: 25 years of image
analysis. Nature Methods, 9, 671–675. doi: 10.
1038/nmeth.2089.
Simara, P., Tesarova, L., Rehakova, D., Matula, P.,
Stejskal, S., Hampl, A., & Koutna, I. (2017).
DNA double-strand breaks in human induced
pluripotent stem cell reprogramming and long-
term in vitro culturing. Stem Cell Research &
Therapy, 8, 73.
Sørensen, C. S., & Syljuåsen, R. G. (2012). Safe-
guarding genome integrity: The checkpoint ki-
nases ATR, CHK1 and WEE1 restrain CDK ac-
tivity during normal DNA replication. Nucleic
Acids Research, 40, 477–486. doi: 10.1093/nar/
gkr697.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita,
M., Ichisaka, T., Tomoda, K., & Yamanaka, S.
(2007). Induction of pluripotent stem cells from
adult human ibroblasts by deined factors. Cell,
131, 861–872. doi: 10.1016/j.cell.2007.11.019.
Thompson, O., VonMeyenn, F., Hewitt, Z., Alexan-
der, J., Wood, A., Weightman, R., … Andrews,
P. W. (2020). Low rates of mutation in clinical
grade human pluripotent stem cells under differ-
ent culture conditions. Nature Communications,
11, 1528. doi: 10.1038/s41467-020-15271-3.
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S.
S., Waknitz, M. A., Swiergiel, J. J., Marshall,
V. S., & Jones, J. M. (1998). Embryonic stem
cell lines derived from human blastocysts. Sci-
ence, 282, 1145–1147. doi: 10.1126/science.
282.5391.1145.
Toledo, L., Neelsen, K. J., & Lukas, J. (2017).
Replication catastrophe: When a checkpoint
fails because of exhaustion.Molecular Cell, 66,
735–749. doi: 10.1016/j.molcel.2017.05.001.
Vallabhaneni, H., Lynch, P. J., Chen, G., Park, K.,
Liu, Y., Goehe, R., … Hursh, D. A. (2018).
High basal levels of γH2AX in human induced
pluripotent stem cells are linked to replication-
associated DNA damage and repair. Stem
Cells, 36, 1501–1513. doi: 10.1002/stem.28
61.
Zhang, J., Hirst, A. J., Duan, F., Qiu, H., Huang,
R., Ji, Y., … Na, J. (2019). Anti-apoptotic mu-
tations desensitize human pluripotent stem cells
to mitotic stress and enable aneuploid cell sur-
vival. Stem Cell Reports, 12, 557–571. doi: 10.
1016/j.stemcr.2019.01.013.Halliwell et al.
16 of 16
Current Protocols in Stem Cell Biology
